GovTrack’s Bill Summary
We don’t have a summary available yet.
Library of Congress Summary
The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.
Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2011 - Authorizes the Director of the Centers for Disease Control and Prevention (CDC) to undertake psoriasis and psoriatic arthritis data collection efforts to collect information regarding:
(1) the prevalence of psoriasis and psoriatic arthritis in the United States;
(2) the age of onset;
(3) health-related quality of life;
(4) health care utilization;
(5) the burden of such disease;
(6) direct and indirect costs;
(7) health disparities, including with respect to age, gender, race, and ethnicity; and
(8) comorbidities and the natural history of such disease.
Allows such data collection efforts to include:
(1) incorporating questions into public health surveys, questionnaires, and other databases in existence as of the date of the enactment of this Act; and
(2) the consideration and development of a patient registry.
Encourages the Director of the National Institutes of Health to explore the development of a virtual Center of Excellence for Collaborative Discovery in Psoriasis and Comorbid Research or some other mechanism through which public and private sector findings regarding psoriasis and its comorbid conditions can be regularly shared and leveraged.
House Republican Conference Summary
The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.
No summary available.
House Democratic Caucus Summary
The House Democratic Caucus does not provide summaries of bills.
So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.
We’ll be looking for a source of summaries from the other side in the meanwhile.